Synthetic peptide corresponding to residues on the N terminal of human DAP Kinase 2.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab51601 in the following tested applications.
|WB||1/1000 - 1/10000. Detects a band of approximately 42 kDa (predicted molecular weight: 42 kDa).|
|IHC-P||Use at an assay dependent concentration.|
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.